Lecture 10 Flashcards
Classical Kinetics
- Predicts blood and tissue levels based on transfer into and out of
“compartments”. - No attempt to model individual organs or tissues.
- Concepts to be discussed:
– One and two compartment models.
– Elimination kinetics.
– Apparent volume of distribution.
– Clearance.
– Half-life.
– Saturation toxicokinetics.
– Bioavailability.
What is Pharmacokinetics?
- A quantitative description of ADME.
- Measured by blood/tissue
concentrations at times after dosing. - End result of kinetics is a biologically
effective (or toxic) dose of the drug.
First Order Elimination
- A nonlinear decrease in drug
concentration over time. - A constant fraction of drug
eliminated per unit time. - Results in constant t1/2 and kel over
time (and dose). - Most common kinetic profile for
drugs.
Zero Order Elimination
- A linear decrease in drug
concentration over time. - A constant amount of drug eliminated
per unit time. - Results in decreasing half-life over
time. - t1/2 and kel depend on the dose and
are not constant. - Seen when a metabolic pathway is
saturated.
Drugs that are stored in fat or are highly protein-bound have
very large Vd (>total body water).
Large drug molecules that cannot leave the blood compartment
have small Vd (<total body water).
Clearance
Clearance
* Clearance (Cl) is the rate of drug elimination from the body expressed as
the volume of fluid containing the xenobiotic that is “cleared” per unit of
time. CL has units of flow (e.g., mL/min)
Half-Life
- The elimination half-life (t1/2) is the time required for the blood or plasma
drug concentration to decrease by 50%. - It is dependent on both Vd and Cl
Bioavailability
- The fraction (F) of the dose of a drug that reaches the
systemic circulation:
– For i.v. dose, F = 1.0.
– For other routes, F = 0 – 1.0
Advantages of PBPK Models
- Provide estimates of the time course of drug distribution to any organ or
tissue. - Allow estimation of the effects of changing physiologic parameters on
organ/tissue concentrations. - Can predict toxicokinetics in different species using “allometric scaling”.
- Complex dosing and processes such as metabolism and binding are
easily accommodated
Disadvantages of PBPK Models
Need lots of data to build a valid model.
Flux
rate of transfer (mg/min) of xenobiotic across a boundary.
– Dependent on permeability coefficient, surface area, and xenobiotic concentration
Perfusion (blood flow) limited
compartment
– Transfer of drug into cells is very rapid.
– Amount of drug that enters cells is limited
only by blood flow into organ
Diffusion (membrane) limited
compartment
– Transfer of drug into cells is slow.
– Amount of drug that enters cells is limited
by flux across cell membranes